Related Experiment Videos

Ex-vivo perfusion of surgically removed organs

S Baba1, K Nakai, K Mizutani

  • 12nd Department of Surgery, Hamamatsu University School of Med., Japan.

Insights

Ex-vivo organ perfusion using FDA-O2, an oxygenated blood substitute, maintained mouse liver viability and ATP levels. This technique shows promise for preserving resected human organs and studying disease pathology.

Area of Science:

  • Biomedical Engineering
  • Organ Perfusion Technology
  • Pathology Research

Background:

  • Maintaining organ viability after surgical resection is critical for transplantation and research.
  • Current methods for preserving resected organs have limitations in sustaining function and preventing ischemic damage.

Purpose of the Study:

  • To evaluate the efficacy of ex-vivo organ perfusion with an oxygenated perfluorochemical blood substitute (FDA-O2) in maintaining organ viability.
  • To assess the potential of this method for analyzing organ function and the histogenesis of pathology.

Main Methods:

  • Surgically resected mouse livers were perfused with oxygenated FDA-O2.
  • Adenosine triphosphate (ATP) levels were monitored during perfusion and reperfusion.
  • Ex-vivo autoradiography was employed to label S phase cells.
  • Absorptive studies were conducted.

Main Results:

  • Perfusion with FDA-O2 maintained normal ATP levels in mouse liver for up to 80 minutes.
  • ATP levels decreased upon perfusion cessation and recovered upon reperfusion, indicating preserved viability.
  • No significant ischemic changes were observed in the perfused organs.
  • Ex-vivo autoradiography successfully labeled S phase cells, demonstrating the utility for cellular analysis.

Conclusions:

  • Ex-vivo organ perfusion with FDA-O2 effectively preserves the viability of resected organs, including human organs.
  • This technique offers a valuable new method for analyzing organ function and understanding the histogenesis of various pathologies.

Related Concept Videos